An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires an urgent need to find effective therapeutics for the treatment of coronavirus disease 2019 (COVID-19). In this study, we developed an integrative drug repositioning framework, which fully takes advantage of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yiyue, Tian, Tingzhong, Huang, Suling, Wan, Fangping, Li, Jingxin, Li, Shuya, Wang, Xiaoting, Yang, Hui, Hong, Lixiang, Wu, Nian, Yuan, Enming, Luo, Yunan, Cheng, Lili, Hu, Chengliang, Lei, Yipin, Shu, Hantao, Feng, Xiaolong, Jiang, Ziyuan, Wu, Yunfu, Chi, Ying, Guo, Xiling, Cui, Lunbiao, Xiao, Liang, Li, Zeng, Yang, Chunhao, Miao, Zehong, Chen, Ligong, Li, Haitao, Zeng, Hainian, Zhao, Dan, Zhu, Fengcai, Shen, Xiaokun, Zeng, Jianyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065335/
https://www.ncbi.nlm.nih.gov/pubmed/33895786
http://dx.doi.org/10.1038/s41392-021-00568-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065335/
https://www.ncbi.nlm.nih.gov/pubmed/33895786
http://dx.doi.org/10.1038/s41392-021-00568-6

Ejemplares similares